항상 최고의 진료를
약속합니다

산부인과(부인종양센터) 노주원 교수

일반진료
오전 진료 진료 1,3,5주
오후 진료 진료

전문분야

부인암, 복막암, 부인과 양성질환(양성종양, 자궁내막증, 자궁선근증), 부인과 내시경수술(로봇수술, 복강경수술, 자궁경수술), 자궁선근증감축술

교수 경력

  • 국립암센터
  • 서울대학교
  • 동국대학교
  • 차의과학대학교

진료 경력

  • MD Anderson Cancer Center
  • 일산동국대학교병원 산부인과 진료과장
  • 차의과학대학교 일산차병원 산부인과
  • 차의과학대학교 일산차병원 부인종양센터

학회·연구·연수·수상 경력

  • 독일 Friedrich-Schiller University 부인종양학 연수
  • 독일 Leipzig University 부인종양학 연수
  • 제 41차 대한암학회 노바티스 Merit award (2015)
  • 제 39차 대한암학회 학술대회 GSK학술상 (2013)
  • Merit Award, in the 10th International Conference of ACOS(2012)

  • 언론기사·영상
  • 논문
  1. Safety and effective of dienogest (Visanne®) for treatment of endometriosis: a large prospective cohort study. Reprod Sci (in publication)
  2. Clinical and biological significance of EZH2 expression in endometrial cancer. Cancer Biol Ther 2019;20:1-10. doi: 10.1080/15384047
  3. Type-specific viral load and physical state of HPV type 16, 18, and 58 as diagnostic biomarkers for high-grade squamous intraepithelial lesions or cervical cancer. Cancer Res Treat 2019; (In publication)
  4. Practice guidelines for management of ovarian cancer in Korea: A Korean Society of Gynecologic Oncology Consensus Statement. J Gynecol Oncol 2018;29(4):e56
  5. Surg Endosc 2018;32:2643-2649
  6. Surgical manual of the Korean Gynecologic Oncology Group: Classification of hysterectomy and lymphadenectomy. J Gynecol Oncol 2017;28(1):e5.
  7. Efficacy and oncologic safety of nerve-sparing radical hysterectomy for cervical cancer: a randomized controlled trial. J Gynecol Oncol, 2015;26(2) :90-99.
  8. Factors Affecting Unused Remaining Volume of Intravenous Patient-controlled Analgesia in Patients Following Laparoscopic Gynecologic Surgery. Asian Nursing Research 2014 Dec8:300-4.
  9. Biological effects of platelet-derived growth factor receptor α blockade in uterine cancer. Clin Cancer Res 2014;May 15;20(10): 2740-50.
  10. Crosstalk between EphA2 and Braf/Craf is a key determinant of response to Dasatinib. Clin Cancer Res 2014 Apr:;20(7):1846-55.
  11. Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma. Gynecol Oncol 2014;Jan;132(1)166-75.
  12. Biologic effects of dopamine on tumor vasculature in ovarian carcinoma. Neoplasia .2013May;15(5):502-10.
  13. Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) in high grade endometrial carcinoma. Gynecol Oncol 2013 Feb;128(2); 344-8.
  14. Clinical and biological relevance of enhancer of zeste homolog 2 in triple negative breast cancer. Human Pathol 2012;43(10):1638-44.
  15. Human papillomavirus genotypes and cofactors causing cervical intraepithelial neoplasia and cervical cancer in Korean women. Int J Gynecol Cancer 2012;22:1570-1576.
  16. A novel platform for detection of CK+ and CK- CTCs. Cancer Discovery 2011;1(7):580-586.
  17. Biological roles of the Delta family notch ligand Dll4 in tumor and endothelial cells in ovarian cancer. Cancer Res.2011;71:6030-6039.
  18. Targeting Src in Mucinous Ovarian Carcinoma. Clin Cancer Res. 2011; 17 (16):5367-78.
  19. A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of a far infrared-emitting sericite belt in patients with primary dysmenorrhea. Complement Ther Med 2011Aug;19(4):187-93
  20. Diastolic forward flow in the fetal main pulmonary artery and its implication for fetal cardiac cycle evaluation. J Perinat Med 2011.2011;39:445-450.
  21. Cyclooxygenase-2 is an independent predictor of poor prognosis in uterine leiomyosarcomas. Int J Gynecol Cancer 2011;21(4):668-672.
  22. Chitosan hydrogel for localized gene silencing. CancerBiolTher2011;11:839-845.
  23. Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles. Neoplasia 2011 Apr;13(4):309-19.
  24. Functional roles of Src and Fgr in ovarian carcinoma. Clin Cancer Res . 2011 Apr 1:17(7):1713-1721.
  25. Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles. Clin Cancer Res 2010;16(15):3910-22.
  26. p53 codon 72 and p21 codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women. Oncol Res 2010;18(9):453-9.
  27. EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma. Clin Cancer Res; 2010;16(9) May: 2562–70.
  28. Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy. J Clin Oncol 2009 Oct20; 27(30): 5088-93.
  29. Successful twin pregnancy after vaginal radical trachelectomy using transabdominal cervicoisthmic cerclage. Am J Obstet Gynecol 2007;197(3):e5-6.
  30. Tumor carbonic anhydrase 9 expression is associated with the presence of lymph node metastases in uterine cervical cancer. Cancer Sci 2007;98:329-333.
  31. Validation study of the Korean version of the M.D. Anderson Symptom Inventory. J Pain Symptom Manag.2006;Apr;31(4):345-52.
  32. Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer. J Cancer Res Clin Oncol 2006;132(5):302-8.
  33. Comparison of accuracies of MRI and PET/CT in presurgical detection of lymph node metastases in patients with uterine cervical cancer: a prospective study. Cancer2006;106(4):914-22.
  34. Single nucleotide polymorphism: a new risk factor for endometrial cancer? Future Oncol 2005;1(3):323-30.
  35. Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: A prospective surgicopathologic correlation study. Eur J Cancer 2005;41(14):2086-92.
  36. Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle. Eur J Nucl Med Mol I 2005;32:757-763.
  37. Pretreatment laparoscopic surgical staging in locally advanced cervical cancer: Preliminary results in Korea. Gynecol Oncol 2005;97(2):468-475.
  38. Validation Study of the Korean Version of the Bried Fatigue Inventory. J Pain Symptom Manag 2005;29:165-172.
  39. Prevalence and Determinants of Genital Infection with Papillomavirus, in Female and Male University. J Infect Dis 2004;190:468-76.
  40. p53 and p21 genetic polymorphism and susceptibility to endometrial cancer. Gynecol Oncol 2004;93:499-505.
  41. Genetic polymorphism of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women. Gynecol Oncol 2004;93:14-18.
  42. Interferon, alpha 17 (IFNA17) Ile 184Arg polymorphism and cervical cancer risk. Cancer Lett 2003;189:183-8.
  43. Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women. Cancer Lett 2002;184:57-63.
  44. A comparison of the therapeutic efficacies of large loop excision of the transformation zone (LLETZ) and hysterectomy for the treatment of cervical intraepithelial neoplasia (CIN) III. Int J Gynecol Cancer 2001;11:387-391.
  45. Polymorphism in Codon 31 of p21 and Cervical Cancer Susceptibility in Korean women. Cancer Lett 2001;165:59-62.
  46. Polymorphism of p53 codon 72 and the risk of cervical cancer in Korean women. Am J Obstet Gynecol 2001;184:55-8.